China
GSK Extends Shingrix Collaboration with Zhifei in China, Explores RSV Vaccine Partnership
GSK, Zhifei, Shingrix, RSV vaccine, Arexvy, China, vaccine collaboration
AstraZeneca Appoints Iskra Reic as New International Operations Lead Following Investigation into China Executive
AstraZeneca, Iskra Reic, Leon Wang, China investigation, international operations lead
Merck’s Gardasil Sales in China Continue to Decline Amid Economic and Regulatory Challenges
Merck, Gardasil, China, vaccine sales, economic challenges, regulatory issues
Eli Lilly Expands Global Innovation Reach with New Research Centers in China
Eli Lilly, China, Research Centers, Innovation, Gateway Labs, Biotechnology, Drug Development
Gilead’s Kite Unit Exits China CAR-T Joint Venture with Fosun
Gilead Sciences, Kite Pharma, Fosun Pharma, CAR-T cell therapy, joint venture, China, Yescarta
Gilead’s Kite Terminates China Cell Therapy Joint Venture with Fosun Pharma
Gilead Sciences, Kite Pharma, Fosun Pharma, cell therapy, joint venture, China, CAR-T therapy, Yescarta
Milestone’s Etripamil Nasal Spray Advances Towards Regulatory Filing in China for PSVT Treatment
Etripamil nasal spray, Paroxysmal supraventricular tachycardia (PSVT), Milestone Pharmaceuticals, Ji Xing Pharmaceuticals Ltd, China regulatory filing, Cardiovascular therapies
Connect Biotech Scales Back in China, Reassesses Strategy for Asthma Drug to Compete with Dupixent
Connect Biotech, China workforce reduction, Dupixent rival, asthma drug strategy, biotech industry
HUTCHMED Withdraws Fruquintinib Application for Second-Line Gastric Cancer Treatment in China
HUTCHMED, fruquintinib, gastric cancer, second-line treatment, China, NDA withdrawal
ReNeuron Exits London Stock Exchange Amid Jacobio’s China Rights Deal
ReNeuron, Jacobio, London Stock Exchange, AIM, China rights deal, biotech, stem cell therapy